Clinical practice advice on lifestyle modification in the management of nonalcoholic fatty liver disease in Japan: an expert review-Reference-Cited by-同舟云学术

Clinical practice advice on lifestyle modification in the management of nonalcoholic fatty liver disease in Japan: an expert review

Published:2021-10-31 Issue:12 Volume:56 Page:1045-1061
ISSN:0944-1174
Container-title:Journal of Gastroenterology
language:en
Short-container-title:J Gastroenterol

Author:

Kamada Yoshihiro^ORCID,Takahashi Hirokazu,Shimizu Masahito,Kawaguchi Takumi,Sumida Yoshio,Fujii Hideki,Seko Yuya,Fukunishi Shinya,Tokushige Katsutoshi,Nakajima Atsushi,Okanoue Takeshi,

Funder

Japan Society for the Promotion of Science

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

https://link.springer.com/content/pdf/10.1007/s00535-021-01833-9.pdf

Reference152 articles.

1. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third national health and nutrition examination survey. JAMA. 2002;287:356–9.

2. Bugianesi E, Leone N, Vanni E, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology. 2002;123:134–40.

3. Simon TG, Roelstraete B, Khalili H, et al. Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort. Gut. 2021;70:1375–82.

4. Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73–84.

5. Chitturi S, Farrell GC, Hashimoto E, et al. Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines. J Gastroenterol Hepatol. 2007;22:778–87.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Self-management in patients with metabolic dysfunction-associated steatotic liver disease: influencing factors and impact on readmission;Journal of Health, Population and Nutrition;2024-08-31

2. Metabolic syndrome is associated with significant hepatic fibrosis and steatosis in patients with nonalcoholic steatohepatitis;iLIVER;2024-06

3. Effectiveness of 1-year pemafibrate treatment on steatotic liver disease: the influence of alcohol consumption;European Journal of Gastroenterology & Hepatology;2024-03-21

4. Quality Evaluation of Metabolic-Associated Fatty Liver Disease Guidelines and Expert Consensus;Hormone and Metabolic Research;2024-01-29

5. Advancements in metabolic‐associated steatotic liver disease research: Diagnostics, small molecule developments, and future directions;Hepatology Research;2024-01-22